首页 > 最新文献

Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis最新文献

英文 中文
Evaluation of the simultaneous effects of KRAS G12V and LCS6 alterations on the behavior of head and neck squamous cell carcinoma 评估 KRAS G12V 和 LCS6 改变同时对头颈部鳞状细胞癌行为的影响。
IF 1.9 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.mrfmmm.2024.111895
Vildan Betul Yenigun , Vasfiye Betul Ucar , Zeynep Betul Sari , Ali Ahmed Azzawri , Yasemin Sena Acar , Muhammed Burak Kaplan , Suleyman Nergiz , Hasan Acar

Background

Head and neck squamous cell carcinomas are the seventh most common cancer accounting for 90 % of malignant neoplasia of the upper respiratory system. KRAS is a very important oncogene, leading to the suppression of apoptosis, and promoting the pathogenesis and development of tumors. MicroRNAs (miRNAs) are highly conserved, small noncoding RNA molecules aberrantly expressed in various pathologies including regulation of tumor and metastasis-associated genes. Variant (rs61764370) of the let-7 miRNA complementary site of KRAS 3’-untranslated region (KRAS-LCS6) has been shown to disrupt the ability of miRNAs to target genes resulting in differential target mRNA and protein expression.

Methods

In this study, the effects of variant complementary site LCS6 of the let-7 miRNA in head and neck cancer were investigated in vitro using laryngeal carcinoma HEp-2 carrying G12V and LCS6 alterations in the KRAS gene. Non-cancer HEK-293 cells were also used as control cells.

Results

G12V mutation in the KRAS gene increases invasion capacity and is specifically active on the ERK pathway associated with metastasis. Alteration in the LCS6 region of the KRAS gene did not show additional effects compared to cells only carrying G12V mutation. Our results also showed that the coexistence of G12V and LCS6 alterations is lethal to specific cell types, UM-SCC-17A laryngeal cancer cells in our case.

Conclusions

The LCS6 region alteration of the KRAS may play a key role in further cancer progression, and more research is needed to fully understand the mechanisms by which the LCS6 alterations promote cancer progression.
背景:头颈部鳞状细胞癌是第七大常见癌症,占上呼吸道恶性肿瘤的90% %。KRAS是一种非常重要的致癌基因,可以抑制细胞凋亡,促进肿瘤的发生发展。MicroRNAs (miRNAs)是高度保守的小非编码RNA分子,在多种病理中异常表达,包括肿瘤和转移相关基因的调控。KRAS 3'-非翻译区(KRAS- lcs6)的let-7 miRNA互补位点的变体(rs61764370)已被证明可以破坏miRNA靶向基因的能力,导致靶mRNA和蛋白的差异表达。方法:本研究采用喉癌HEp-2携带G12V和LCS6 KRAS基因改变的方法,体外研究let-7 miRNA变异互补位点LCS6在头颈癌中的作用。非癌性HEK-293细胞也作为对照细胞。结果:KRAS基因的G12V突变增加了侵袭能力,并在与转移相关的ERK通路上特别活跃。与仅携带G12V突变的细胞相比,KRAS基因LCS6区域的改变没有显示出额外的影响。我们的研究结果还表明,G12V和LCS6的共存改变对特定的细胞类型是致命的,在我们的病例中是UM-SCC-17A喉癌细胞。结论:KRAS的LCS6区域改变可能在癌症进一步进展中发挥关键作用,需要更多的研究来充分了解LCS6改变促进癌症进展的机制。
{"title":"Evaluation of the simultaneous effects of KRAS G12V and LCS6 alterations on the behavior of head and neck squamous cell carcinoma","authors":"Vildan Betul Yenigun ,&nbsp;Vasfiye Betul Ucar ,&nbsp;Zeynep Betul Sari ,&nbsp;Ali Ahmed Azzawri ,&nbsp;Yasemin Sena Acar ,&nbsp;Muhammed Burak Kaplan ,&nbsp;Suleyman Nergiz ,&nbsp;Hasan Acar","doi":"10.1016/j.mrfmmm.2024.111895","DOIUrl":"10.1016/j.mrfmmm.2024.111895","url":null,"abstract":"<div><h3>Background</h3><div><span><span>Head and neck </span>squamous cell carcinomas are the seventh most common cancer accounting for 90 % of malignant neoplasia of the upper respiratory system. </span><span><span>KRAS</span></span><span><span> is a very important oncogene, leading to the suppression of </span>apoptosis<span>, and promoting the pathogenesis and development of tumors. MicroRNAs<span> (miRNAs) are highly conserved, small noncoding RNA molecules aberrantly expressed in various pathologies including regulation of tumor and metastasis-associated genes. Variant (rs61764370) of the let-7 miRNA complementary site of </span></span></span><em>KRAS</em><span> 3’-untranslated region (KRAS-LCS6) has been shown to disrupt the ability of miRNAs to target genes resulting in differential target mRNA and protein expression.</span></div></div><div><h3>Methods</h3><div><span>In this study, the effects of variant complementary site LCS6 of the let-7 miRNA in head and neck cancer were investigated </span><em>in vitro</em><span> using laryngeal carcinoma HEp-2 carrying G12V and LCS6 alterations in the </span><em>KRAS</em> gene. Non-cancer HEK-293 cells were also used as control cells.</div></div><div><h3>Results</h3><div>G12V mutation in the <em>KRAS</em><span> gene increases invasion capacity and is specifically active on the ERK pathway associated with metastasis. Alteration in the LCS6 region of the </span><em>KRAS</em><span> gene did not show additional effects compared to cells only carrying G12V mutation. Our results also showed that the coexistence of G12V and LCS6 alterations is lethal to specific cell types, UM-SCC-17A laryngeal cancer cells in our case.</span></div></div><div><h3>Conclusions</h3><div>The LCS6 region alteration of the <em>KRAS</em> may play a key role in further cancer progression, and more research is needed to fully understand the mechanisms by which the LCS6 alterations promote cancer progression.</div></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"831 ","pages":"Article 111895"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High expression of SLC34A2 contributes to chemoresistance of non-small cell lung cancer against gefitinib: The critical role of miR-124–3p SLC34A2的高表达导致了非小细胞肺癌对吉非替尼的化疗耐药性:miR-124-3p 的关键作用。
IF 1.9 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.mrfmmm.2024.111894
Chao Tan , Li Zhang , Sai Chen , Zhenzhen Tian , Nina Zhou , Yuling Li , Qi Wang , Lu Chen
Gefitinib is a therapeutic agent used to treat lung carcinoma, including non-small cell lung cancer (NSCLC). However, mechanisms underlying NSCLC cell resistance to gefitinib remain largely uncharacterized. In this study, we explored the association between the miR-124–3p/SLC34A2 axis and gefitinib resistance using a series of in vivo and in vitro assays. Data indicated that miR-124–3p is downregulated, while SLC34A2 is upregulated, in gefitinib-resistant NSCLC cells. Overexpression of miR-124–3p reduced NSCLC cell resistance to gefitinib by suppressing cell viability, inducing apoptosis, and decreasing N-cadherin expression. Conversely, inhibiting miR-124–3p in NSCLC cells led to increased cell viability and reduced apoptosis. Overexpression of SLC34A2 in NSCLC cells further heightened gefitinib resistance. In a xenograft mouse model, SLC34A2 overexpression promoted solid tumor growth and metastasis, while miR-124–3p overexpression inhibited these effects. Our results highlight that the interaction between miR-124–3p and SLC34A2 plays an indispensable role in determining gefitinib resistance in NSCLC cells.
吉非替尼是一种用于治疗包括非小细胞肺癌(NSCLC)在内的肺癌的药物。然而,NSCLC细胞对吉非替尼耐药的机制在很大程度上仍未定性。在这项研究中,我们利用一系列体内和体外试验探索了 miR-124-3p/SLC34A2 轴与吉非替尼耐药性之间的关联。数据表明,在吉非替尼耐药的 NSCLC 细胞中,miR-124-3p 下调,而 SLC34A2 上调。miR-124-3p的过表达通过抑制细胞活力、诱导细胞凋亡和减少N-cadherin的表达,降低了NSCLC细胞对吉非替尼的耐药性。相反,抑制NSCLC细胞中的miR-124-3p可提高细胞活力,减少细胞凋亡。NSCLC 细胞中 SLC34A2 的过表达进一步增强了吉非替尼的抗药性。在异种移植小鼠模型中,SLC34A2 的过表达促进了实体瘤的生长和转移,而 miR-124-3p 的过表达则抑制了这些效应。我们的研究结果突出表明,miR-124-3p与SLC34A2之间的相互作用在决定NSCLC细胞对吉非替尼的耐药性方面起着不可或缺的作用。
{"title":"High expression of SLC34A2 contributes to chemoresistance of non-small cell lung cancer against gefitinib: The critical role of miR-124–3p","authors":"Chao Tan ,&nbsp;Li Zhang ,&nbsp;Sai Chen ,&nbsp;Zhenzhen Tian ,&nbsp;Nina Zhou ,&nbsp;Yuling Li ,&nbsp;Qi Wang ,&nbsp;Lu Chen","doi":"10.1016/j.mrfmmm.2024.111894","DOIUrl":"10.1016/j.mrfmmm.2024.111894","url":null,"abstract":"<div><div><span><span>Gefitinib is a therapeutic agent used to treat </span>lung carcinoma<span>, including non-small cell lung cancer (NSCLC). However, mechanisms underlying NSCLC cell resistance to gefitinib remain largely uncharacterized. In this study, we explored the association between the miR-124–3p/SLC34A2 axis and gefitinib resistance using a series of </span></span><em>in vivo</em> and <em>in vitro</em><span><span><span> assays. Data indicated that miR-124–3p is downregulated, while SLC34A2 is upregulated, in gefitinib-resistant NSCLC cells. Overexpression of miR-124–3p reduced NSCLC cell resistance to gefitinib by suppressing </span>cell viability, inducing </span>apoptosis<span><span><span>, and decreasing N-cadherin expression. Conversely, inhibiting miR-124–3p in NSCLC cells led to increased cell viability and reduced apoptosis. Overexpression of SLC34A2 in NSCLC cells further heightened gefitinib resistance. In a </span>xenograft mouse model, SLC34A2 overexpression promoted </span>solid tumor growth and metastasis, while miR-124–3p overexpression inhibited these effects. Our results highlight that the interaction between miR-124–3p and SLC34A2 plays an indispensable role in determining gefitinib resistance in NSCLC cells.</span></span></div></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"831 ","pages":"Article 111894"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The mechanism underlying the oncogenic potential of AAA+ ATPase PSMC4 in cancer is revealed by mutations and copy number amplifications AAA+ atp酶PSMC4在癌症中的致癌潜力机制通过突变和拷贝数扩增揭示
IF 1.9 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.mrfmmm.2025.111901
Sanjida Mallick , Qurratulain Qamar , Bibhudutta Mishra , Aditi Nayak
Recent research has discovered a connection between the AAA+ ATPase PSMC4 (Proteasome 26S Subunit, ATPase 4) and several forms of cancer. However, a detailed analysis of the oncogenic potential of PSMC4 was elusive. In this study, we anticipate PSMC4's potential as a cancer biomarker. We aimed to comprehensively assess the expression profiles, prognostic significance, and relevant cellular pathways associated with it. Through our examination of various types of cancers, PSMC4 is found to be overexpressed. Interestingly, our result finds a positive correlation between PSMC4 overexpression and unfavourable overall survival rates in cancer. Further, we looked into the mutations and copy number amplifications of PSMC4 across various cancers. Our study reveals that missense mutations plays a great role behind the oncogenic potential of PSMC4. Several possible mutation sites are predicted. Interestingly, we found fifteen hotspot mutations in the ATPase domain of PSMC4. Additionally, PSMC4 has shown a high amplification percentage in various cancers. We are additionally attentive to the functional characteristics of the protein PSMC4 across various types of cancer. In the protein-protein interaction analyses, it was found that multiple oncoproteins were directly interacting with PSMC4. The top signaling pathways of PSMC4 also indicate that it plays a crucial role in cancer development. Overall, this study reveals that PSMC4 could be a potential diagnostic and prognostic marker for cancer, making it a promising biomarker and target.
最近的研究发现了AAA+ atp酶PSMC4(蛋白酶体26S亚基,atp酶4)和几种癌症之间的联系。然而,PSMC4的致癌潜能的详细分析是难以捉摸的。在这项研究中,我们预测PSMC4作为癌症生物标志物的潜力。我们的目的是全面评估表达谱、预后意义以及与之相关的细胞通路。通过我们对各种类型癌症的检查,发现PSMC4过度表达。有趣的是,我们的结果发现PSMC4过表达与癌症中不利的总生存率呈正相关。此外,我们研究了PSMC4在各种癌症中的突变和拷贝数扩增。我们的研究表明错义突变在PSMC4的致癌潜能背后起着重要作用。预测了几个可能的突变位点。有趣的是,我们在PSMC4的atp酶结构域发现了15个热点突变。此外,PSMC4在各种癌症中显示出很高的扩增百分比。我们还关注PSMC4蛋白在不同类型癌症中的功能特征。在蛋白-蛋白相互作用分析中,发现多种癌蛋白直接与PSMC4相互作用。PSMC4的顶级信号通路也表明它在癌症发展中起着至关重要的作用。总之,本研究表明PSMC4可能是一个潜在的癌症诊断和预后标志物,使其成为一个有前景的生物标志物和靶点。
{"title":"The mechanism underlying the oncogenic potential of AAA+ ATPase PSMC4 in cancer is revealed by mutations and copy number amplifications","authors":"Sanjida Mallick ,&nbsp;Qurratulain Qamar ,&nbsp;Bibhudutta Mishra ,&nbsp;Aditi Nayak","doi":"10.1016/j.mrfmmm.2025.111901","DOIUrl":"10.1016/j.mrfmmm.2025.111901","url":null,"abstract":"<div><div><span><span>Recent research has discovered a connection between the AAA+ ATPase<span> PSMC4 (Proteasome 26S Subunit, ATPase 4) and several forms of cancer. However, a detailed analysis of the oncogenic potential of PSMC4 was elusive. In this study, we anticipate PSMC4's potential as a cancer biomarker. We aimed to comprehensively assess the expression profiles, prognostic significance, and relevant cellular pathways associated with it. Through our examination of various types of cancers, PSMC4 is found to be overexpressed. Interestingly, our result finds a positive correlation between PSMC4 overexpression and unfavourable </span></span>overall survival rates in cancer. Further, we looked into the mutations and copy number amplifications of PSMC4 across various cancers. Our study reveals that </span>missense mutations<span><span> plays a great role behind the oncogenic potential of PSMC4. Several possible mutation sites are predicted. Interestingly, we found fifteen hotspot mutations in the ATPase domain of PSMC4. Additionally, PSMC4 has shown a high amplification percentage in various cancers. We are additionally attentive to the functional characteristics of the protein PSMC4 across various types of cancer. In the protein-protein interaction analyses, it was found that multiple </span>oncoproteins<span> were directly interacting with PSMC4. The top signaling pathways of PSMC4 also indicate that it plays a crucial role in cancer development. Overall, this study reveals that PSMC4 could be a potential diagnostic and prognostic marker for cancer, making it a promising biomarker and target.</span></span></div></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"831 ","pages":"Article 111901"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143464973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ATM and ATR gene editing mediated by CRISPR/Cas9 in Chinese Hamster cells CRISPR/Cas9 在中国仓鼠细胞中介导的 ATM 和 ATR 基因编辑
IF 1.5 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.mrfmmm.2024.111871
Junko Maeda, Piyawan Chailapakul, Takamitsu A. Kato

Chinese hamster-derived cell lines including Chinese hamster lung fibroblasts (V79) have been used as model somatic cell lines in radiation biology and toxicology research for decades and have been instrumental in advancing our understanding of DNA damage response (DDR) mechanisms. Whereas many mutant lines deficient in DDR genes have been generated more than over decades, several key DDR genes such as ATM and ATR have not been established in the Chinese hamster system. Here, we transfected CRISPR/Cas9 vectors targeting Chinese hamster ATM or ATR into V79 cells and investigated whether the isolated clones had the characteristics reported in human and mouse studies. We obtained two clones of ATM knockout cells containing an insertion or deletions in the targeted locus. The ATM knockouts with no detectable ATM protein expression exhibited increased sensitivity to radiation and DNA double strand break inducing agents, cell cycle checkpoint defects and defective chromatid break repair. These are all characteristics of defective ATM function. Among the obtained ATR cells, which contained mutations in both ATR alleles while maintaining normal levels of ATR protein expression, one clone exhibited hypersensitivity to UV and replication stress agents. In the present study, we successfully established CRISPR-Cas9 derived ATM knockout cells. We couldn't knock out the ATR gene but obtained ATR mutant cells. Our results showed that Chinese hamster origin ATM knockout cells and ATR mutant cells could be useful tools for further research to reveal oncogenic functions and effects of developing anti-cancer therapeutics.

几十年来,包括中国仓鼠肺成纤维细胞(V79)在内的中国仓鼠衍生细胞系一直被用作辐射生物学和毒理学研究中的模式体细胞系,并在促进我们对 DNA 损伤应答(DDR)机制的了解方面发挥了重要作用。虽然几十年来已经产生了许多缺乏 DDR 基因的突变株,但一些关键的 DDR 基因(如 ATM 和 ATR)尚未在中国仓鼠系统中建立。在这里,我们将靶向中国仓鼠ATM或ATR的CRISPR/Cas9载体转染到V79细胞中,并研究分离出的克隆是否具有人类和小鼠研究中报道的特征。我们获得了两个ATM基因敲除细胞克隆,它们在靶向基因座上都有插入或缺失。没有检测到ATM蛋白表达的ATM基因敲除细胞表现出对辐射和DNA双链断裂诱导剂的敏感性增加、细胞周期检查点缺陷和染色体断裂修复缺陷。这些都是 ATM 功能缺陷的特征。在获得的ATR细胞中,两个ATR等位基因都发生了突变,但ATR蛋白表达水平保持正常,其中一个克隆对紫外线和复制胁迫剂表现出超敏反应。在本研究中,我们成功建立了 CRISPR-Cas9 衍生的 ATM 基因敲除细胞。我们未能敲除ATR基因,但获得了ATR突变细胞。我们的研究结果表明,中国仓鼠来源的ATM基因敲除细胞和ATR突变细胞可以成为进一步研究揭示致癌功能和开发抗癌疗法效果的有用工具。
{"title":"ATM and ATR gene editing mediated by CRISPR/Cas9 in Chinese Hamster cells","authors":"Junko Maeda,&nbsp;Piyawan Chailapakul,&nbsp;Takamitsu A. Kato","doi":"10.1016/j.mrfmmm.2024.111871","DOIUrl":"10.1016/j.mrfmmm.2024.111871","url":null,"abstract":"<div><p>Chinese hamster-derived cell lines including Chinese hamster lung fibroblasts (V79) have been used as model somatic cell lines in radiation biology and toxicology research for decades and have been instrumental in advancing our understanding of DNA damage response (DDR) mechanisms. Whereas many mutant lines deficient in DDR genes have been generated more than over decades, several key DDR genes such as ATM and ATR have not been established in the Chinese hamster system. Here, we transfected CRISPR/Cas9 vectors targeting Chinese hamster ATM or ATR into V79 cells and investigated whether the isolated clones had the characteristics reported in human and mouse studies. We obtained two clones of ATM knockout cells containing an insertion or deletions in the targeted locus. The ATM knockouts with no detectable ATM protein expression exhibited increased sensitivity to radiation and DNA double strand break inducing agents, cell cycle checkpoint defects and defective chromatid break repair. These are all characteristics of defective ATM function. Among the obtained ATR cells, which contained mutations in both ATR alleles while maintaining normal levels of ATR protein expression, one clone exhibited hypersensitivity to UV and replication stress agents. In the present study, we successfully established CRISPR-Cas9 derived ATM knockout cells. We couldn't knock out the ATR gene but obtained ATR mutant cells. Our results showed that Chinese hamster origin ATM knockout cells and ATR mutant cells could be useful tools for further research to reveal oncogenic functions and effects of developing anti-cancer therapeutics.</p></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"829 ","pages":"Article 111871"},"PeriodicalIF":1.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141638930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the nucleotide composition and patterns of codon usage in the expression of human oral cancer genes 了解人类口腔癌基因表达中的核苷酸组成和密码子使用模式
IF 1.5 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.mrfmmm.2024.111880
Tarikul Huda Mazumder , Arif Uddin

Oral squamous cell carcinoma (OSCC) is primarily known as oral cancer (OC) that mostly occurs in mouth, lips and tongue. Mutations in some of the genes cause OC and some genes are risk factors for progression of OC. In this study, we analyzed the compositional features and pattern of codon usage in genes involved in OC using computational method as no work was reported yet. Compositional features suggested that the overall GC content was higher i.e. genes were GC rich. Effective number of codons (ENC) values ranged from 34.6 to 55.9 with a mean value of 49.03±4.22 representing low codon usage bias (CUB). Correspondence analysis (COA) suggested that the codon usage pattern was different in different genes. In genes associated with OC, highly significant correlation was observed between GC12 and GC3 (r=0.454, p<0.01) suggesting that directional mutation affected all the three codon positions. This is the first report on pattern of codon usage pattern on genes involved in OC, which not only alludes a new perspective for elucidating the mechanisms of biased usage of synonymous codons but also provide valuable clues for molecular genetic engineering.

口腔鳞状细胞癌(OSCC)主要称为口腔癌(OC),多发于口腔、嘴唇和舌头。有些基因突变会导致口腔鳞状细胞癌,有些基因则是口腔鳞状细胞癌恶化的危险因素。在本研究中,我们利用计算方法分析了 OC 相关基因的组成特征和密码子使用模式。组成特征表明,基因的整体 GC 含量较高,即富含 GC。有效密码子数(ENC)值在 34.6 至 55.9 之间,平均值为 49.03±4.22,代表低密码子使用偏差(CUB)。对应分析(COA)表明,不同基因的密码子使用模式不同。在与 OC 相关的基因中,观察到 GC12 和 GC3 之间存在高度显著的相关性(r=0.454,p<0.01),表明定向突变影响了所有三个密码子位置。这是首次报道涉及 OC 基因的密码子使用模式,不仅为阐明同义密码子的偏向使用机制提供了新的视角,而且为分子遗传工程提供了有价值的线索。
{"title":"Understanding the nucleotide composition and patterns of codon usage in the expression of human oral cancer genes","authors":"Tarikul Huda Mazumder ,&nbsp;Arif Uddin","doi":"10.1016/j.mrfmmm.2024.111880","DOIUrl":"10.1016/j.mrfmmm.2024.111880","url":null,"abstract":"<div><p>Oral squamous cell carcinoma (OSCC) is primarily known as oral cancer (OC) that mostly occurs in mouth, lips and tongue. Mutations in some of the genes cause OC and some genes are risk factors for progression of OC. In this study, we analyzed the compositional features and pattern of codon usage in genes involved in OC using computational method as no work was reported yet. Compositional features suggested that the overall GC content was higher <em>i.e.</em> genes were GC rich. Effective number of codons (ENC) values ranged from 34.6 to 55.9 with a mean value of 49.03±4.22 representing low codon usage bias (CUB). Correspondence analysis (COA) suggested that the codon usage pattern was different in different genes. In genes associated with OC, highly significant correlation was observed between GC12 and GC3 (r=0.454, p&lt;0.01) suggesting that directional mutation affected all the three codon positions. This is the first report on pattern of codon usage pattern on genes involved in OC, which not only alludes a new perspective for elucidating the mechanisms of biased usage of synonymous codons but also provide valuable clues for molecular genetic engineering.</p></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"829 ","pages":"Article 111880"},"PeriodicalIF":1.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142084355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Agrimonolide inhibits glycolysis in ovarian cancer cells by regulating HIF1A 嘧菌酯通过调节 HIF1A 抑制卵巢癌细胞中的糖酵解作用
IF 1.5 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.mrfmmm.2024.111884
Yi Yang, Huimin Wang, Qiong Wei, Chun Li

Background

Ovarian cancer is one of the most common tumors affecting females, significantly disrupting their quality of life. Agrimonolide, an extract derived from Agrimony (Agrimonia pilosa Ledeb.), has been shown to exert various regulatory effects on several diseases. Notably, recent studies indicate that Agrimonolide may attenuate the progression of ovarian cancer. However, the detailed regulatory mechanisms of Agrimonolide in this context require further investigation.

Purpose

To determine the significance of HIF1A as a key target in ovarian cancer and its potential underlying signaling pathway.

Methods

Cell viability and proliferation were assessed using CCK-8 and colony formation assays. Glucose uptake and lactate production were measured using commercial kits, and the extracellular acidification rate (ECAR) was evaluated. Protein expression levels were analyzed through western blotting.

Results

Our network pharmacology analysis identified HIF1A as a crucial target and signaling pathway in ovarian cancer. Furthermore, treatment with Agrimonolide (20 μM and 40 μM) inhibited the growth of ovarian cancer cells. Agrimonolide also reduced glycolytic activity in these cells. Additionally, Agrimonolide treatment led to decreased expression levels of HIF1A, HK2, and LDHA in ovarian cancer cells. Rescue assays revealed that glucose uptake and lactate production were diminished following Agrimonolide treatment; however, these effects were reversed upon overexpression of HIF1A.

Conclusion

This study showed that Agrimonolide can suppress glycolysis in ovarian cancer cells by modulating HIF1A, supporting Agrimonolide as a promising therapeutic agent for ovarian cancer treatment.
背景卵巢癌是女性最常见的肿瘤之一,严重影响女性的生活质量。从枸杞(Agrimonia pilosa Ledeb.)中提取的枸杞内酯(Agrimonolide)已被证明对多种疾病具有不同的调节作用。值得注意的是,最近的研究表明,Agrimonolide 可减轻卵巢癌的进展。目的 确定 HIF1A 作为卵巢癌关键靶点的重要性及其潜在的信号通路。方法 使用 CCK-8 和集落形成试验评估细胞活力和增殖。使用商业试剂盒测量葡萄糖摄取量和乳酸生成量,并评估细胞外酸化率(ECAR)。结果我们的网络药理学分析确定 HIF1A 是卵巢癌的关键靶点和信号通路。此外,用阿格列莫内酯(20 μM 和 40 μM)处理可抑制卵巢癌细胞的生长。阿格列莫内酯还能降低这些细胞的糖酵解活性。此外,Agrimonolide 还能降低卵巢癌细胞中 HIF1A、HK2 和 LDHA 的表达水平。这项研究表明,阿格莫内酯可通过调节 HIF1A 来抑制卵巢癌细胞中的糖酵解,从而支持阿格莫内酯成为一种治疗卵巢癌的有效药物。
{"title":"Agrimonolide inhibits glycolysis in ovarian cancer cells by regulating HIF1A","authors":"Yi Yang,&nbsp;Huimin Wang,&nbsp;Qiong Wei,&nbsp;Chun Li","doi":"10.1016/j.mrfmmm.2024.111884","DOIUrl":"10.1016/j.mrfmmm.2024.111884","url":null,"abstract":"<div><h3>Background</h3><div>Ovarian cancer is one of the most common tumors affecting females, significantly disrupting their quality of life. Agrimonolide, an extract derived from Agrimony (<em>Agrimonia pilosa</em> Ledeb.), has been shown to exert various regulatory effects on several diseases. Notably, recent studies indicate that Agrimonolide may attenuate the progression of ovarian cancer. However, the detailed regulatory mechanisms of Agrimonolide in this context require further investigation.</div></div><div><h3>Purpose</h3><div>To determine the significance of HIF1A as a key target in ovarian cancer and its potential underlying signaling pathway.</div></div><div><h3>Methods</h3><div>Cell viability and proliferation were assessed using CCK-8 and colony formation assays. Glucose uptake and lactate production were measured using commercial kits, and the extracellular acidification rate (ECAR) was evaluated. Protein expression levels were analyzed through western blotting.</div></div><div><h3>Results</h3><div>Our network pharmacology analysis identified HIF1A as a crucial target and signaling pathway in ovarian cancer. Furthermore, treatment with Agrimonolide (20 μM and 40 μM) inhibited the growth of ovarian cancer cells. Agrimonolide also reduced glycolytic activity in these cells. Additionally, Agrimonolide treatment led to decreased expression levels of HIF1A, HK2, and LDHA in ovarian cancer cells. Rescue assays revealed that glucose uptake and lactate production were diminished following Agrimonolide treatment; however, these effects were reversed upon overexpression of HIF1A.</div></div><div><h3>Conclusion</h3><div>This study showed that Agrimonolide can suppress glycolysis in ovarian cancer cells by modulating HIF1A, supporting Agrimonolide as a promising therapeutic agent for ovarian cancer treatment.</div></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"829 ","pages":"Article 111884"},"PeriodicalIF":1.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ALDH2 mutations and defense against genotoxic aldehydes in cancer and inherited bone marrow failure syndromes 癌症和遗传性骨髓衰竭综合征中的 ALDH2 基因突变和对基因毒性醛的防御。
IF 1.5 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.mrfmmm.2024.111870
Anthony Yiu-Ho Woo, Lina Jia

Reactive aldehydes, for instance, formaldehyde and acetaldehyde, are important endogenous or environmental mutagens by virtue of their abilities to produce a DNA lesion called interstrand crosslink (ICL). Aldehyde-metabolizing enzymes such as aldehyde dehydrogenases (ALDHs) and the Fanconi anemia (FA) pathway constitute the main defense lines against aldehyde-induced genotoxicity. Biallelic mutations of genes in any one of the FA complementation groups can impair the ICL repair mechanism and cause FA, a heterogeneous disorder manifested by bone marrow failure (BMF), congenital abnormality and a strong predisposition to cancer. The defective ALDH2 polymorphism rs671 (ALDH2*2) is a known risk and prognostic factor for alcohol drinking-associated cancers. Recent studies suggest that it also promotes BMF and cancer development in FA, and its combination with alcohol dehydrogenase 5 (ADH5) mutations causes aldehyde degradation deficiency syndrome (ADDS), also known by its symptoms as aplastic anemia, mental retardation, and dwarfism syndrome. ALDH2*2 and another pathogenic variant in the alcohol-metabolizing pathway, ADH1B1*1, is prevalent among East Asians. Also, other ALDH2 genotypes with disease-modifying potentials have lately been identified in different populations. Therefore, it would be appropriate to summarize current knowledge of genotoxic aldehydes and defense mechanisms against them to shed new light on the pathogenic effects of ALDH2 variants together with other genetic and environmental modifiers on cancer and inherited BMF syndromes. Lastly, we also presented potential treatment strategies for FA, ADDS and cancer based on the manipulation of aldehyde-induced genotoxicity.

反应性醛(如甲醛和乙醛)是重要的内源性或环境诱变剂,因为它们能够产生一种称为链间交联(ICL)的 DNA 病变。醛代谢酶(如醛脱氢酶(ALDHs))和范可尼贫血症(FA)途径是抵御醛诱导的遗传毒性的主要防线。FA互补组中任何一个基因的双倍突变都会损害ICL修复机制,导致FA这种表现为骨髓衰竭(BMF)、先天畸形和极易罹患癌症的异质性疾病。已知有缺陷的 ALDH2 多态性 rs671(ALDH2*2)是饮酒相关癌症的风险和预后因素。最近的研究表明,它还会促进 BMF 和 FA 中癌症的发生,它与酒精脱氢酶 5(ADH5)突变结合会导致醛降解缺陷综合征(ADDS),该综合征也被称为再生障碍性贫血、智力迟钝和侏儒综合征。ALDH2*2 和酒精代谢途径中的另一种致病变体 ADH1B1*1 在东亚人中很普遍。此外,最近还在不同人群中发现了其他具有改变疾病潜能的 ALDH2 基因型。因此,我们有必要总结一下目前有关基因毒性醛类及其防御机制的知识,以揭示 ALDH2 基因变异及其他遗传和环境因素对癌症和遗传性 BMF 综合征的致病作用。最后,我们还介绍了在控制醛诱导的遗传毒性的基础上治疗 FA、ADDS 和癌症的潜在策略。
{"title":"ALDH2 mutations and defense against genotoxic aldehydes in cancer and inherited bone marrow failure syndromes","authors":"Anthony Yiu-Ho Woo,&nbsp;Lina Jia","doi":"10.1016/j.mrfmmm.2024.111870","DOIUrl":"10.1016/j.mrfmmm.2024.111870","url":null,"abstract":"<div><p>Reactive aldehydes, for instance, formaldehyde and acetaldehyde, are important endogenous or environmental mutagens by virtue of their abilities to produce a DNA lesion called interstrand crosslink (ICL). Aldehyde-metabolizing enzymes such as aldehyde dehydrogenases (ALDHs) and the Fanconi anemia (FA) pathway constitute the main defense lines against aldehyde-induced genotoxicity. Biallelic mutations of genes in any one of the FA complementation groups can impair the ICL repair mechanism and cause FA, a heterogeneous disorder manifested by bone marrow failure (BMF), congenital abnormality and a strong predisposition to cancer. The defective <em>ALDH2</em> polymorphism rs671 (<em>ALDH2*2</em>) is a known risk and prognostic factor for alcohol drinking-associated cancers. Recent studies suggest that it also promotes BMF and cancer development in FA, and its combination with alcohol dehydrogenase 5 (ADH5) mutations causes aldehyde degradation deficiency syndrome (ADDS), also known by its symptoms as aplastic anemia, mental retardation, and dwarfism syndrome. <em>ALDH2*2</em> and another pathogenic variant in the alcohol-metabolizing pathway, <em>ADH1B1*1</em>, is prevalent among East Asians. Also, other <em>ALDH2</em> genotypes with disease-modifying potentials have lately been identified in different populations. Therefore, it would be appropriate to summarize current knowledge of genotoxic aldehydes and defense mechanisms against them to shed new light on the pathogenic effects of <em>ALDH2</em> variants together with other genetic and environmental modifiers on cancer and inherited BMF syndromes. Lastly, we also presented potential treatment strategies for FA, ADDS and cancer based on the manipulation of aldehyde-induced genotoxicity.</p></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"829 ","pages":"Article 111870"},"PeriodicalIF":1.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141474098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt/β-catenin pathway in triple-negative breast cancer AQP5通过激活三阴性乳腺癌中的Wnt/β-catenin通路促进上皮-间质转化和肿瘤生长
IF 1.5 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.mrfmmm.2024.111868
Zhengcai Zhu, Tao Li, Honggang Wang, Lianghe Jiao

Background

Emerging data identifies aquaporin 5 (AQP5) as a vital player in many kinds of cancers. Over expression of AQP5 was associated with increased metastasis and poor prognosis, suggesting that AQP5 may facilitate cancer cell proliferation and migration. Our previous studies also showed that AQP3 and AQP5 were highly expressed in triple-negative breast cancer (TNBC) and the expression of AQP3 and AQP5 in TNBC tissue was positive correlated with advanced clinical stage.

Objective

We aim to investigate the role of AQP5 in TNBC oncogenesis and development.

Methods

MDA-MB-231 cells were transfected with siRNA-AQP5 and AQP5 overexpression vector to establish a differential expression system for AQP5. Cell proliferation and apoptosis of MDA-MB-231 cells were detected by CCK-8 (Cell Counting Kit-8) and FCM (flow cytometry), respectively. Cell migration and invasion abilities were evaluated by wound healing assay and transwell assay. The qRT-PCR and western blot assays were used to study the effect of AQP5 expression level on the expression of epithelial-to-mesenchymal transition (EMT) related molecules. The effects of ICG-001, a Wnt/β-catenin signaling pathway inhibitor, on the invasive and migratory capabilities of overexpressed AQP5 cells and downstream molecules were measured.

Results

1. The expression of AQP5 in the MDA-MB-231 cells was significantly higher than that in the MCF-10A cells. 2. Up-regulation of AQP5 significantly promoted the proliferation, migration and invasion of TNBC cells, while inhibited the cell apoptosis; in addition, up-regulation of AQP5 increased the expression of Bcl-2 and decreased the expression of Caspase-3. However, knockdown of AQP5 presented the adverse effects of AQP5 overexpression. 3. Overexpressed AQP5 induced the overexpression of EMT-related factors, which further promoted the migration and invasion of cells. 4. Overexpression of AQP5 could up-regulate the expression of β-catenin in the nucleus followed by increasing the expression levels of downstream genes in Wnt/β-catenin signaling pathway. Moreover, ICG-001, the inhibitor of Wnt/β-catenin signaling pathway, could significantly attenuate the effect of overexpression of AQP5 on cells, further confirming that AQP5 may promote the proliferation, migration and invasion of TNBC cells by activating Wnt/β-catenin signaling pathway.

Conclusions

In the TNBC cells, AQP5 modulates the expression levels of EMT-related proteins through activation of Wnt/β-catenin signaling pathway, thus enhancing the cell proliferation, migration and invasion while inhibiting the cell apoptosis.

背景:越来越多的数据表明,水蒸气素 5(AQP5)在多种癌症中发挥着重要作用。AQP5 的过度表达与转移增加和预后不良有关,这表明 AQP5 可能会促进癌细胞的增殖和迁移。我们之前的研究也表明,AQP3 和 AQP5 在三阴性乳腺癌(TNBC)中高表达,且 AQP3 和 AQP5 在 TNBC 组织中的表达与晚期临床分期呈正相关:我们旨在研究 AQP5 在 TNBC 肿瘤发生和发展过程中的作用:方法:用 siRNA-AQP5 和 AQP5 过表达载体转染 MDA-MB-231 细胞,建立 AQP5 差异表达系统。分别用 CCK-8(细胞计数试剂盒-8)和 FCM(流式细胞术)检测 MDA-MB-231 细胞的增殖和凋亡。细胞迁移和侵袭能力通过伤口愈合试验和透孔试验进行评估。qRT-PCR 和 Western 印迹检测用于研究 AQP5 表达水平对上皮细胞向间质转化(EMT)相关分子表达的影响。还测定了Wnt/β-catenin信号通路抑制剂ICG-001对过表达AQP5细胞的侵袭和迁移能力及下游分子的影响:1.1. AQP5在MDA-MB-231细胞中的表达量明显高于MCF-10A细胞。2.2. AQP5的上调能明显促进TNBC细胞的增殖、迁移和侵袭,同时抑制细胞凋亡;此外,AQP5的上调能增加Bcl-2的表达,降低Caspase-3的表达。然而,敲除AQP5会出现AQP5过表达的不良反应。3.过表达的 AQP5 会诱导 EMT 相关因子的过表达,从而进一步促进细胞的迁移和侵袭。4.4. AQP5的过表达可上调细胞核中β-catenin的表达,进而增加Wnt/β-catenin信号通路下游基因的表达水平。此外,Wnt/β-catenin信号通路抑制剂ICG-001能显著减弱AQP5过表达对细胞的影响,进一步证实了AQP5可通过激活Wnt/β-catenin信号通路促进TNBC细胞的增殖、迁移和侵袭:结论:在 TNBC 细胞中,AQP5 通过激活 Wnt/β-catenin 信号通路调节 EMT 相关蛋白的表达水平,从而在抑制细胞凋亡的同时促进细胞增殖、迁移和侵袭。
{"title":"AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt/β-catenin pathway in triple-negative breast cancer","authors":"Zhengcai Zhu,&nbsp;Tao Li,&nbsp;Honggang Wang,&nbsp;Lianghe Jiao","doi":"10.1016/j.mrfmmm.2024.111868","DOIUrl":"10.1016/j.mrfmmm.2024.111868","url":null,"abstract":"<div><h3>Background</h3><p>Emerging data identifies aquaporin 5 (AQP5) as a vital player in many kinds of cancers. Over expression of AQP5 was associated with increased metastasis and poor prognosis, suggesting that AQP5 may facilitate cancer cell proliferation and migration. Our previous studies also showed that AQP3 and AQP5 were highly expressed in triple-negative breast cancer (TNBC) and the expression of AQP3 and AQP5 in TNBC tissue was positive correlated with advanced clinical stage.</p></div><div><h3>Objective</h3><p>We aim to investigate the role of AQP5 in TNBC oncogenesis and development.</p></div><div><h3>Methods</h3><p>MDA-MB-231 cells were transfected with siRNA-AQP5 and AQP5 overexpression vector to establish a differential expression system for AQP5. Cell proliferation and apoptosis of MDA-MB-231 cells were detected by CCK-8 (Cell Counting Kit-8) and FCM (flow cytometry), respectively. Cell migration and invasion abilities were evaluated by wound healing assay and transwell assay. The qRT-PCR and western blot assays were used to study the effect of AQP5 expression level on the expression of epithelial-to-mesenchymal transition (EMT) related molecules. The effects of ICG-001, a Wnt/β-catenin signaling pathway inhibitor, on the invasive and migratory capabilities of overexpressed AQP5 cells and downstream molecules were measured.</p></div><div><h3>Results</h3><p>1. The expression of AQP5 in the MDA-MB-231 cells was significantly higher than that in the MCF-10A cells. 2. Up-regulation of AQP5 significantly promoted the proliferation, migration and invasion of TNBC cells, while inhibited the cell apoptosis; in addition, up-regulation of AQP5 increased the expression of Bcl-2 and decreased the expression of Caspase-3. However, knockdown of AQP5 presented the adverse effects of AQP5 overexpression. 3. Overexpressed AQP5 induced the overexpression of EMT-related factors, which further promoted the migration and invasion of cells. 4. Overexpression of AQP5 could up-regulate the expression of β-catenin in the nucleus followed by increasing the expression levels of downstream genes in Wnt/β-catenin signaling pathway. Moreover, ICG-001, the inhibitor of Wnt/β-catenin signaling pathway, could significantly attenuate the effect of overexpression of AQP5 on cells, further confirming that AQP5 may promote the proliferation, migration and invasion of TNBC cells by activating Wnt/β-catenin signaling pathway.</p></div><div><h3>Conclusions</h3><p>In the TNBC cells, AQP5 modulates the expression levels of EMT-related proteins through activation of Wnt/β-catenin signaling pathway, thus enhancing the cell proliferation, migration and invasion while inhibiting the cell apoptosis.</p></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"829 ","pages":"Article 111868"},"PeriodicalIF":1.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141500041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HOXA1 promotes epithelial-mesenchymal transition and malignant characteristics of laryngeal squamous cell carcinoma HOXA1 促进上皮-间质转化和喉鳞癌的恶性特征。
IF 1.5 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.mrfmmm.2024.111882
Jun Wu, Xiaofeng Gu

Despite considerable advancements in the diagnosis and treatment of LSCC, there has been no significant improvement in survival rate. Consequently, identifying molecular targets for this cancer is of paramount importance. HOXA1, a constituent of the homeobox transcription factor cluster, plays a role in the development of various types of cancer. Nevertheless, the specific function and mechanism of HOXA1 in LSCC remains unclear. This study aimed to clarify the impact of HOXA1 on the advancement of LSCC and uncover its underlying mechanism. Our findings indicate that HOXA1 exhibits a significantly elevated expression level in LSCC. Suppression of HOXA1 inhibited the proliferation of LSCC cells. Furthermore, the ablation of HOXA1 triggered the apoptosis of LSCC cells and inhibited EMT. Functionally, HOXA1 has a role in initiating the activation of the PI3K/AKT/mTOR pathway in LSCC cells. In summary, HOXA1 significantly contributes to the EMT of LSCC cells via the PI3K/AKT/mTOR signaling pathway, thereby facilitating the proliferation and motility of LSCC cells. Consequently, HOXA1 presents itself as a viable therapeutic target for LSCC interventions.

尽管 LSCC 的诊断和治疗取得了长足的进步,但存活率却没有明显提高。因此,确定这种癌症的分子靶点至关重要。HOXA1是homeobox转录因子集群的一个组成部分,在各种癌症的发展中起着重要作用。然而,HOXA1在LSCC中的具体功能和机制仍不清楚。本研究旨在阐明HOXA1对LSCC进展的影响,并揭示其潜在机制。我们的研究结果表明,HOXA1在LSCC中的表达水平明显升高。抑制HOXA1可抑制LSCC细胞的增殖。此外,消融HOXA1可诱导LSCC细胞凋亡并抑制EMT。从功能上看,HOXA1 在激活 LSCC 细胞的 PI3K/AKT/mTOR 通路中发挥作用。总之,HOXA1通过PI3K/AKT/mTOR信号通路显著促进了LSCC细胞的EMT,从而促进了LSCC细胞的增殖和运动。因此,HOXA1可作为干预LSCC的可行治疗靶点。
{"title":"HOXA1 promotes epithelial-mesenchymal transition and malignant characteristics of laryngeal squamous cell carcinoma","authors":"Jun Wu,&nbsp;Xiaofeng Gu","doi":"10.1016/j.mrfmmm.2024.111882","DOIUrl":"10.1016/j.mrfmmm.2024.111882","url":null,"abstract":"<div><p>Despite considerable advancements in the diagnosis and treatment of LSCC, there has been no significant improvement in survival rate. Consequently, identifying molecular targets for this cancer is of paramount importance. HOXA1, a constituent of the homeobox transcription factor cluster, plays a role in the development of various types of cancer. Nevertheless, the specific function and mechanism of HOXA1 in LSCC remains unclear. This study aimed to clarify the impact of HOXA1 on the advancement of LSCC and uncover its underlying mechanism. Our findings indicate that HOXA1 exhibits a significantly elevated expression level in LSCC. Suppression of HOXA1 inhibited the proliferation of LSCC cells. Furthermore, the ablation of HOXA1 triggered the apoptosis of LSCC cells and inhibited EMT. Functionally, HOXA1 has a role in initiating the activation of the PI3K/AKT/mTOR pathway in LSCC cells. In summary, HOXA1 significantly contributes to the EMT of LSCC cells via the PI3K/AKT/mTOR signaling pathway, thereby facilitating the proliferation and motility of LSCC cells. Consequently, HOXA1 presents itself as a viable therapeutic target for LSCC interventions.</p></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"829 ","pages":"Article 111882"},"PeriodicalIF":1.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142147240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The RAD51 S181P mutation shortens lifespan of female mice RAD51 S181P 突变会缩短雌性小鼠的寿命
IF 1.5 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.mrfmmm.2024.111878
Sherry G. Dodds , Gene Hubbard , Yong Jun Choi , Kyungjae Myung , Gene Elliot , Lisa Garrett , Tae Moon Kim , Paul Hasty

RAD51 is critical to the homologous recombination (HR) pathway that repairs DNA double strand breaks (DSBs) and protects replication forks (RFs). Previously, we showed that the S181P (SP) mutation in RAD51 causes defective RF maintenance but is proficient for DSB repair. Here we report that SP/SP female mice exhibit a shortened lifespan compared to +/+ females but not males. Histological analysis found that most mice in this study died from lymphoma, independent of genotype and sex. We propose that a potential cause for shortened lifespan in SP/SP females is due to the RF defect.

RAD51 对同源重组(HR)途径至关重要,它能修复 DNA 双链断裂(DSB)并保护复制叉(RF)。此前,我们发现 RAD51 的 S181P(SP)突变会导致 RF 维护缺陷,但却能进行 DSB 修复。在这里,我们报告了与 +/+ 雌性小鼠相比,SP/SP 雌性小鼠的寿命缩短,而雄性小鼠则没有。组织学分析发现,本研究中的大多数小鼠死于淋巴瘤,与基因型和性别无关。我们认为,SP/SP雌鼠寿命缩短的潜在原因是射频缺陷。
{"title":"The RAD51 S181P mutation shortens lifespan of female mice","authors":"Sherry G. Dodds ,&nbsp;Gene Hubbard ,&nbsp;Yong Jun Choi ,&nbsp;Kyungjae Myung ,&nbsp;Gene Elliot ,&nbsp;Lisa Garrett ,&nbsp;Tae Moon Kim ,&nbsp;Paul Hasty","doi":"10.1016/j.mrfmmm.2024.111878","DOIUrl":"10.1016/j.mrfmmm.2024.111878","url":null,"abstract":"<div><p>RAD51 is critical to the homologous recombination (HR) pathway that repairs DNA double strand breaks (DSBs) and protects replication forks (RFs). Previously, we showed that the S181P (SP) mutation in <em>RAD51</em> causes defective RF maintenance but is proficient for DSB repair. Here we report that SP/SP female mice exhibit a shortened lifespan compared to +/+ females but not males. Histological analysis found that most mice in this study died from lymphoma, independent of genotype and sex. We propose that a potential cause for shortened lifespan in SP/SP females is due to the RF defect.</p></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"829 ","pages":"Article 111878"},"PeriodicalIF":1.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0027510724000289/pdfft?md5=39f47dbaabdae7ba92ee31eea49d1079&pid=1-s2.0-S0027510724000289-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141991132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1